RESUMEN
CONTEXT: Soy formula feeding is common in infancy and is a source of high exposure to phytoestrogens, documented to influence vaginal cytology in female infants. Its influence on minipuberty in males has not been established. OBJECTIVE: To assess the association between infant feeding practice and longitudinally measured reproductive hormones and hormone-responsive tissues in infant boys. METHODS: The Infant Feeding and Early Development study was a prospective cohort of maternal-infant dyads requiring exclusive soy formula, cow milk formula, or breast milk feeding during study follow-up. In the 147 infant boy participants, serum testosterone, luteinizing hormone, stretched penile length, anogenital distance, and testis volume were longitudinally assessed from birth to 28 weeks. We examined feeding-group differences in age trajectories for these outcomes using mixed-effects regression splines. RESULTS: Median serum testosterone was at pubertal levels at 2 weeks (176 ng/dL [quartiles: 124, 232]) and remained in this range until 12 weeks in all feeding groups. We did not observe differences in trajectories of hormone concentrations or anatomical measures between boys fed soy formula (nâ =â 55) and boys fed cow milk formula (nâ =â 54). Compared with breastfed boys (nâ =â 38), soy formula-fed boys had a more rapid increase in penile length (Pâ =â .004) and slower initial lengthening of anogenital distance (Pâ =â .03), but no differences in hormone trajectories. CONCLUSION: Reproductive hormone concentrations and anatomical responses followed similar trajectories in soy and cow milk formula-fed infant boys. Our findings suggest that these measures of early male reproductive development do not respond to phytoestrogen exposure during infancy.
Asunto(s)
Genitales Masculinos/anatomía & histología , Glycine max , Fórmulas Infantiles , Fitoestrógenos/farmacología , Testosterona/sangre , Adulto , Lactancia Materna , Femenino , Humanos , Lactante , Hormona Luteinizante/sangre , Masculino , Pene/anatomía & histología , Pene/crecimiento & desarrollo , Estudios Prospectivos , Testículo/anatomía & histologíaRESUMEN
A multicenter, open-label, randomized, controlled superiority trial with 18 months of follow-up was conducted to investigate whether oral zinc supplementation could further promote spermatogenesis in males with isolated hypogonadotropic hypogonadism (IHH) receiving sequential purified urinary follicular-stimulating hormone/human chorionic gonadotropin (uFSH/hCG) replacement. Sixty-seven Chinese male IHH patients were recruited from the Departments of Endocrinology in eight tertiary hospitals and randomly allocated into the sequential uFSH/hCG group (Group A, n = 34) or the sequential uFSH plus zinc supplementation group (Group B, n = 33). In Group A, patients received sequential uFSH (75 U, three times a week every other 3 months) and hCG (2000 U, twice a week) treatments. In Group B, patients received oral zinc supplementation (40 mg day-1 ) in addition to the sequential uFSH/hCG treatment given to patients in Group A. The primary outcome was the proportion of patients with a sperm concentration ≥1.0 × 106 ml-1 during the 18 months. The comparison of efficacy between Groups A and B was analyzed. Nineteen of 34 (55.9%) patients receiving sequential uFSH/hCG and 20 of 33 (60.6%) patients receiving sequential uFSH/hCG plus zinc supplementation achieved sperm concentrations ≥1.0 × 106 ml-1 by intention to treat analyses. No differences between Group A and Group B were observed as far as the efficacy of inducing spermatogenesis (P = 0.69). We concluded that the sequential uFSH/hCG plus zinc supplementation regimen had a similar efficacy to the sequential uFSH/hCG treatment alone. The additional improvement of 40 mg day-1 oral zinc supplementation on spermatogenesis and masculinization in male IHH patients is very subtle.
Asunto(s)
Suplementos Dietéticos , Gonadotropinas/deficiencia , Hipogonadismo/tratamiento farmacológico , Oligoelementos/uso terapéutico , Zinc/uso terapéutico , Adolescente , Adulto , Gonadotropina Coriónica/sangre , Hormona Folículo Estimulante/sangre , Humanos , Hormona Luteinizante/sangre , Masculino , Persona de Mediana Edad , Pene/anatomía & histología , Pene/efectos de los fármacos , Recuento de Espermatozoides , Motilidad Espermática/efectos de los fármacos , Espermatogénesis/efectos de los fármacos , Testículo/anatomía & histología , Testículo/efectos de los fármacos , Testosterona/sangre , Resultado del Tratamiento , Adulto JovenRESUMEN
PURPOSE: Prospective evaluation of sexual outcomes after prostate brachytherapy with iodine-125 seeds as monotherapy at a tertiary cancer care center. METHODS AND MATERIALS: Subjects were 129 men with prostate cancer with I-125 seed implants (prescribed dose, 145 Gy) without supplemental hormonal or external beam radiation therapy. Sexual function, potency, and bother were prospectively assessed at baseline and at 1, 4, 8, and 12 months using validated quality-of-life self-assessment surveys. Postimplant dosimetry values, including dose to 10% of the penile bulb (D10), D20, D33, D50, D75, D90, and penile volume receiving 100% of the prescribed dose (V100) were calculated. RESULTS: At baseline, 56% of patients recorded having optimal erections; at 1 year, 62% of patients with baseline erectile function maintained optimal potency, 58% of whom with medically prescribed sexual aids or drugs. Variables associated with pretreatment-to-posttreatment decline in potency were time after implant (p = 0.04) and age (p = 0.01). Decline in urinary function may have been related to decline in potency. At 1 year, 69% of potent patients younger than 70 years maintained optimal potency, whereas 31% of patients older than 70 maintained optimal potency (p = 0.02). Diabetes was related to a decline in potency (p = 0.05), but neither smoking nor hypertension were. For patients with optimal potency at baseline, mean sexual bother scores had declined significantly at 1 year (p < 0.01). Sexual potency, sexual function, and sexual bother scores failed to correlate with any dosimetric variable tested. CONCLUSIONS: Erections firm enough for intercourse can be achieved at 1 year after treatment, but most men will require medical aids to optimize potency. Although younger men were better able to maintain erections firm enough for intercourse than older men, there was no correlation between potency, sexual function, or sexual bother and penile bulb dosimetry.
Asunto(s)
Braquiterapia/efectos adversos , Disfunción Eréctil/terapia , Erección Peniana/efectos de la radiación , Pene/efectos de la radiación , Neoplasias de la Próstata/radioterapia , Anciano , Anciano de 80 o más Años , Braquiterapia/métodos , Coito , Disfunción Eréctil/fisiopatología , Humanos , Radioisótopos de Yodo/uso terapéutico , Masculino , Persona de Mediana Edad , Erección Peniana/fisiología , Pene/anatomía & histología , Estudios ProspectivosRESUMEN
INTRODUCTION: Epidemiologic studies exploring sexuality across different cultures and geographic regions are scanty, particularly from the Middle East. The Global Online Sexuality Survey (GOSS) is an Internet-based survey investigating male and female sexual function. GOSS-Arabic-Males is the Arabic version targeting males in the Middle East, exploring prevalence rate of and factors affecting erectile dysfunction and its therapeutic trends, as well as premature ejaculation, attitudes toward genital size, and contraception. AIM: To explore epidemiologic aspects of male sexuality through an online survey. MAIN OUTCOME MEASURES: Prevalence rate of erectile dysfunction, its relationship to risk factors, and therapeutic trends. METHODS: The online survey was randomly offered to Web surfers in the Middle East. RESULTS: Eight hundred four subjects completed the survey. The overall prevalence of ED was 45.1%, strongly correlating with various risk factors studied, including age, diabetes, hypertension under treatment, depression, concerns over genital size, interpersonal distress, premature ejaculation, low libido, and subjective reports of penile deviation. Adjusted to the World Standard Population, the prevalence rate for ED was 47%. Phosphodiesterase (PDE) inhibitors gave a poor response among those with low libido and interpersonal distress, emphasizing the need for proper diagnosis and psychological counseling parallel to medical treatment. Furthermore, PDE inhibitors were stigmatized with unrealistic concerns that decreased their utility to a great extent. CONCLUSION: In the study population of Arab-speaking Internet users, prevalence of erectile dysfunction and effect of risk factors have proven similar to reports from different parts of the world, though not unanimously. Premature ejaculation, low desire, concerns over penile size, and penile curvature are factors to be considered in the evaluation of ED patients. PDE inhibitors are stigmatized with false beliefs that should be addressed through mass media and counseling if this population is to take full benefit from this therapeutic option.
Asunto(s)
Disfunción Eréctil/epidemiología , Adulto , Anciano , Terapias Complementarias , Disfunción Eréctil/etiología , Disfunción Eréctil/terapia , Femenino , Encuestas Epidemiológicas , Humanos , Internet , Masculino , Persona de Mediana Edad , Medio Oriente , Tamaño de los Órganos , Pene/anatomía & histología , Inhibidores de Fosfodiesterasa 5/efectos adversos , Inhibidores de Fosfodiesterasa 5/uso terapéutico , Prevalencia , Factores de Riesgo , Adulto JovenRESUMEN
OBJECTIVES: To study the presentations and treatment outcome of 8 consecutive patients for whom cod liver oil was injected in the subcutaneous area of their penises by a lay person for purpose of augmentation. METHODS: Various amounts of cod liver oil were injected in the subcutaneous area of the penis of 8 low socioeconomic class patients by a nonmedical person. They presented by various complications ranging from paraphimosis up to abscess formation and necrosis of penile skin. All the patients underwent emergency initial surgical intervention ranging from dorsal preputial slit to skin debridement. Definitive surgical treatment was carried out using local penile flap and V-Y plasty. RESULTS: The severity of complications was correlated to the amount of oil injected and the time interval between injections and presentation. All the 8 patients were cured after different staged surgical procedures. The postoperative course was uneventful in 6 patients, and 2 patients suffered from wound infection after the secondary treatment. All patients had acceptable cosmetic and functional outcome, and were satisfied regarding the length of the penis. None reported erectile dysfunction. CONCLUSIONS: Increased public awareness is indicated to avoid this problem. Early detection and prompt treatment give acceptable anatomic and functional results.
Asunto(s)
Aceite de Hígado de Bacalao/administración & dosificación , Técnicas Cosméticas , Pene , Adulto , Humanos , Inyecciones Subcutáneas , Masculino , Persona de Mediana Edad , Tamaño de los Órganos , Pene/anatomía & histologíaRESUMEN
Mercury intoxication is rare. Most often it is associated with occupational exposure or suicide attempts. We present the case of a 72-year-old patient who received a subcutaneous injection of metallic mercury into his penis for the purpose of penile aesthetic augmentation. Total phallectomy and perineal urethrostomy was performed, followed by chelation therapy. To our knowledge, this is the first report of penile subcutaneous mercury injection for aesthetic augmentation.
Asunto(s)
Mercurio/administración & dosificación , Pene/anatomía & histología , Anciano , Técnicas Cosméticas , Humanos , Inyecciones Subcutáneas , MasculinoRESUMEN
Functional anatomy of the human penis involves various parameters: cavernous tissue, covering integument, prepuce foreskin, corpora cavernosa, corpus spongiosum, glans, facia, arterial supply, venous drainage, lymph drainage, musculature, and nerve supply. Several factors affect the expression/degree of erectile dysfunction (ED) endocrine profile, aging/senescence, demyelinating diseases, and surgery. Risk factors of ED are: age, vascular factors, metabolic diseases (diabetes mellitus), neurologic diseases, and HIV/AIDS. Several drugs are associated with ED: antiandrogenic, anticholinergic, antidepressants, antihypertensive, major tranquilizers, anxiolytics, and certain medicines/metabolites. The International Index of Erectile Function (IIEF) is a multidimensional scale for assessment of erectile dysfunction. The main structures mediating erection are the corpora cavernosa or "erectile bodies," which are fused distally for approximately three-quarters of their length. They separate proximally to fuse with each ischial tuberosity of the pelvis. On their ventral surface lies the corpus spongiosum, which surrounds the urethra. Coital dysfunction is classified into "erectile dysfunction" (psychosexual and endocrine/neuro-endocrine) and "ejaculatory dysfunction" (psychosexual, and genitourinary surgery). Vasculogenic impotence was evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Cavernosal, alpha-blockade is a technique used to evaluate and treat ED. Another diagnostic procedure for ED involves color floro and spectural Doppler imaging after papaverine-induced erection in impotent men. Color Doppler and duplex ultrasonography are used to evaluate Peyronie's disease. Sildenafil cilrate (Viagra) is an effective therapy of ED in men. Vardenavil is a highly selective phosphodiesterase 5 (PDE5) inhibitor which improved ED. Prostagland E1, vasoactive intestinal polypeptide (VIP), and phentolamine mesylate (administered by autoinjectors) have been applied to treat ED in patients resistant to other intracavernosal agents. Clinical trials were conducted on self-injection of vasoactive drugs, apomorphine SL, and tadalafil in diabetic men. Medical therapy of ED includes: medicated urethral system for erection (MUSE), intravenous pharmacotherapy, arterial revascularization, vacuum devices, two- and three-component inflatable penile prosthesis, semi-rigid penile prosthesis in situ, and inflatable one-piece penile prosthesis. Surgical therapy include procedures to correct Peyronie's penile deformity and penile deformity, procedures to avoid inevitable shortening accompanying Nesbit's disease, and for penile lengthening.
Asunto(s)
Disfunción Eréctil , Disfunción Eréctil/diagnóstico , Disfunción Eréctil/etiología , Disfunción Eréctil/terapia , Humanos , Masculino , Pene/anatomía & histología , Pene/fisiopatologíaAsunto(s)
Hombres/psicología , Pene/crecimiento & desarrollo , Adulto , Humanos , Masculino , Persona de Mediana Edad , Pene/anatomía & histología , Siliconas , España , Factores de Tiempo , YogaRESUMEN
Se hace una amplia descripción anatómica de las estructuras del pene, las indicaciones y contraindicaciones de la circuncición y de las técnicas quirúrgicas disponibles, con especial alternativa la sinequiotomía, que es la liberación del prepucio por despegamiento del glande; este procedimiento se puede efectuar después del cuarto o quinto mes de edad
Asunto(s)
Recién Nacido , Humanos , Masculino , Pene/anatomía & histología , Pene/embriología , Fimosis/cirugía , Procedimientos Quirúrgicos Operativos , Procedimientos Quirúrgicos Operativos , Circuncisión Masculina , Circuncisión Masculina , Circuncisión Masculina , Anestesia Local , Anestesia Local , Lidocaína/uso terapéuticoAsunto(s)
Eicosanoides/fisiología , Disfunción Eréctil/fisiopatología , Erección Peniana/fisiología , Animales , Neuropatías Diabéticas/prevención & control , Disfunción Eréctil/tratamiento farmacológico , Ácidos Grasos Esenciales/farmacología , Ácidos Grasos Esenciales/uso terapéutico , Humanos , Ácidos Linoleicos , Masculino , Óxido Nítrico/fisiología , Nucleótidos Cíclicos/fisiología , Oenothera biennis , Erección Peniana/efectos de los fármacos , Pene/anatomía & histología , Pene/fisiología , Aceites de Plantas , Prostaglandinas/metabolismo , Ácido gammalinolénicoRESUMEN
There are no absolutes regarding circumcision, and the decision to circumcise a child as a newborn or otherwise must be made after carefully weighing the alternatives to, and risks and benefits of, this common surgical procedure. These alternatives, risks, and benefits must be fully explained to parents considering circumcision, and informed consent must be obtained. In well-trained, experienced hands, circumcision is a safe procedure that effectively eliminates proven problems such as cancer of the penis, and may eliminate the problems of increased risk of urinary tract infection and sexually transmitted diseases.
Asunto(s)
Circuncisión Masculina , Anestesia Local , Circuncisión Masculina/efectos adversos , Humanos , Recién Nacido , Masculino , Bloqueo Nervioso , Pene/anatomía & histología , Enfermedades de Transmisión Sexual/complicaciones , Infecciones Urinarias/prevención & controlRESUMEN
Ritual circumcision of males has been practiced for millennia, but was limited to fewer than 20 per cent of the world's population. About a century ago, only the English-speaking countries adopted non-religious circumcision as a prophylactic or therapeutic panacea for myriad ailments. Since these "health" claims are now known to be unsubstantiated, the English-speaking countries either abandoned the practice or reduced the frequency of its performance; the only exception is the United States. This article examines the background for this enigma and suggests solutions.
Asunto(s)
Circuncisión Masculina , Australia , Canadá , Circuncisión Masculina/historia , Circuncisión Masculina/estadística & datos numéricos , Circuncisión Masculina/tendencias , Historia del Siglo XIX , Historia del Siglo XX , Historia Antigua , Humanos , Higiene , Recién Nacido , Masculino , Dolor , Neoplasias del Pene/prevención & control , Pene/anatomía & histología , Pene/cirugía , Enfermedades de Transmisión Sexual/prevención & control , Esmegma/fisiología , Estados UnidosRESUMEN
Small quantities of diethylstilbestrol and testosterone proprionate were implanted into the hypothalamic arcuate nucleus of male rats of the Wistar-Imamichi strain at 43 days of age. The animals were sacrificed at 64 or 76 days of age. Diethylstilbestrol suppressed the development of all genital organs and disturbed spermatogenesis. The damage was found to have recovered slightly in rats sacrificed at 76 days of age. Testosterone propionate was also effective for the atrophy of some genital organs. Its influence was not so severe as that of diethylstilbestrol. It extinguished almost completely 33 days after implantation. On the contrary, the numbers of spermatogonia and spermatocytes per cross section of the seminiferous tubule were smaller at 76 days than at 64 days of age. The diameter of the seminiferous tubule in the rat implanted with testosterone propionate was longer at 76 days than at 64 days of age. Therefore, the tubular diameter did not always represent the quantity or quality of spermatogenesis. The results also suggested that spermatogenesis might have been disturbed in some of the rats in which androgen was considered to be secreted almost normally.
Asunto(s)
Dietilestilbestrol/farmacología , Hipotálamo/efectos de los fármacos , Espermatogénesis/efectos de los fármacos , Testosterona/farmacología , Animales , Peso Corporal , Glándulas Bulbouretrales/anatomía & histología , Epidídimo/anatomía & histología , Masculino , Tamaño de los Órganos , Pene/anatomía & histología , Próstata/anatomía & histología , Ratas , Vesículas Seminales/anatomía & histología , Espermatozoides/citología , Testículo/anatomía & histología , Factores de Tiempo , Conducto Deferente/anatomía & histologíaRESUMEN
Electrolytic lesions of the hypothalamic medial forebrain bundle (MFB) produced substantial deficits in the copulatory behavior of male rats, but no changes in testicular, seminal vesicle, ventral prostate or penis weights. Radioimmunoassay of serum from lesioned and control animals revealed a small but statistically insignificant reduction in testosterone and LH levels, and no change in FSH levels of lesioned males. In a second experiment, androgen levels were maintained in castrated males by subcutaneous implants of silastic capsules containing crystalline testosterone; this procedure failed to prevent the copulatory deficit which accompanied subsequent MFB lesions. We have concluded that the behavioral deficit produced by such lesions is not a direct result of pituitary-gonadal dysfunction.